Firms

Hadean Ventures

Hadean Ventures

hadeanventures.com

Hadean Ventures is a European venture capital manager investing in life-science companies developing medicines, medical devices, diagnostics and digital health products. From offices in Oslo and Stockholm, it focuses particularly on the Nordic region and German-speaking Europe and supports companies across development stages. Its portfolio includes seizure monitoring using artificial intelligence, neurological drug discovery and digital mental-health treatments. Its investment team combines scientific expertise, venture investing and operational experience.

Founded
—
Type
Venture capital

Funds1

  • Hadean Capital II€144M

    European life-science venture fund investing in pharmaceuticals, biotechnology, medical devices, diagnostics and digital health, with emphasis on the Nordic and German-speaking markets. Its EUR 144 million final close was announced on December 21, 2023, above its EUR 125 million target. The same fund launched in September 2021; the 2023 announcement is its final close rather than a separate fund launch.

Team

Operations and support

Camilla OlsenImpact & ESG Manager
Florian EckhardtSenior Advisor
Georgina AskelandPrincipal
Ingrid Teigland AkayManaging Partner
Lene DragesundSenior Office Manager
Lene GerlachVenture Partner
Markus DietrichSenior Investment Associate
Markéta ChlubnováInvestment Analyst
Miao HeSenior Investment Associate
Nora KaarelaVenture Partner
Paal August NordhagenDirector of Finance & Controlling
Pål R. JensenSenior Advisor Operations
Reinhard KricklVenture Partner
Roger FranklinPartner
Silje C. L. ErvikHead of Legal
Vilde FredheimDirector, Investor Relations & Business Development
Walter StockingerManaging Partner
Yun YangInvestment Associate

Co-investing

Catalyze Capital
Innovestor
Investinor
Maki.vc
SHS Capital

Investments